Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ParkerVision, Inc. - Common Stock (OP:PRKR)

0.3245 +0.0345 (+11.90%)
Streaming Delayed Price Updated: 9:53 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,148
Open 0.2968
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2900
Today's Range 0.2900 - 0.3245
52wk Range 0.0920 - 1.180
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ParkerVision Asks Court to Delay Patent Infringement Trial Against Qualcomm Until Appeal of 2025 Claim Construction Order is Adjudicated
Via ACCESS Newswire
ParkerVision Responds to Court Ruling in Long-Running Patent Case Against Qualcomm
Via ACCESS Newswire

Performance

YTD
-62.3%
-62.3%
1 Month
-7.3%
-7.3%
3 Month
-29.5%
-29.5%
6 Month
-64.3%
-64.3%
1 Year
+177.8%
+177.8%

More News

Read More
ParkerVision Announces Filing of Shelf Registration Statement
Via ACCESS Newswire
ParkerVision Reports First Quarter 2025 Results
Via ACCESS Newswire
Director Sanford Litvack Leaves ParkerVision Board
Via ACCESS Newswire
ParkerVision Reports Third Quarter 2024 Results
Via ACCESSWIRE
ParkerVision v. Qualcomm Sent Back to Florida for Trial After Appellate Court Overturns District Court in a Precedential Ruling
Via ACCESSWIRE
ParkerVision Reports Second Quarter 2024 Results
Via ACCESSWIRE
ParkerVision Reports First Quarter 2024 Results
Via ACCESSWIRE
ParkerVision Files Registration Statement on Form S-3 for Previously Issued Securities
Via ACCESS Newswire
ParkerVision Reports 2024 Results
Via ACCESS Newswire
Updated: Patently Strategic Podcast, Highlighting Former Federal Judges Supporting Grant of ParkerVision's petition to US Supreme Court, Driving New Interest in the Case This Week
Via ACCESS Newswire
Patently Strategic Podcast Highlights Consensus of Two Former Federal Judges Supporting Grant of ParkerVision's Petition to US Supreme Court
Via ACCESS Newswire
ParkerVision Reports 2023 Results
Via ACCESSWIRE
ParkerVision Reports Profitable First Half of 2023
Via ACCESSWIRE
ParkerVision Reports Profitable First Quarter 2023
Via ACCESSWIRE
ParkerVision Launches "Against the Giants" Video Series Highlighting Ongoing Litigation
Via ACCESS Newswire
ParkerVision Receives Favorable Markman Rulings in Infringement Actions Against MediaTek and Realtek
Via ACCESSWIRE
ParkerVision Responds to OTC Markets Promotion Policy Request
Via ACCESSWIRE
ParkerVision Reports $10.6 Million in Net Income for First Nine Months of 2023
Via ACCESSWIRE
Oral Arguments in ParkerVision v. Qualcomm Scheduled for November 6, 2023
Via ACCESSWIRE
ParkerVision Reports 2022 Results
Via ACCESSWIRE
Lewis Titterton Rejoins ParkerVision Board of Directors
Via ACCESSWIRE
ParkerVision Files Complaints Against Texas Instruments and NXP Semiconductors for Patent Infringement
Via ACCESSWIRE
ParkerVision Files New Complaints Against MediaTek and Realtek for Patent Infringement
Via ACCESSWIRE

Frequently Asked Questions

Is ParkerVision, Inc. - Common Stock publicly traded?
Yes, ParkerVision, Inc. - Common Stock is publicly traded.
What exchange does ParkerVision, Inc. - Common Stock trade on?
ParkerVision, Inc. - Common Stock trades on the OTC Traded
What is the ticker symbol for ParkerVision, Inc. - Common Stock?
The ticker symbol for ParkerVision, Inc. - Common Stock is PRKR on the OTC Traded
What is the current price of ParkerVision, Inc. - Common Stock?
The current price of ParkerVision, Inc. - Common Stock is 0.3245
When was ParkerVision, Inc. - Common Stock last traded?
The last trade of ParkerVision, Inc. - Common Stock was at 07/07/25 09:53 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.